Sam Kant

11PUBLICATIONS
16CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 14, 2025
Novel Biomarkers for Rejection in Kidney Transplantation: A Comprehensive Review.

Michael Strader, Sam Kant

|Jan 16, 2024
Outcomes and management of kidney transplant recipients with Fabry disease: a review.

Bo Yu, Mohamed G Atta, Daniel C Brennan

|Dec 23, 2023
Measures to Increase Immunogenicity of SARS-CoV-2 Vaccines in Solid Organ Transplant Recipients: A Narrative Review.

Bo Yu, Christina Tamargo, Daniel C Brennan

|Jun 28, 2023
Pathophysiology of Rejection in Kidney Transplantation.

Christina L Tamargo, Sam Kant

|Mar 10, 2023
Master protocol to assess the long-term safety in kidney transplant recipients who previously received Medeor's cellular immunotherapy products: the MDR-105-SAE.

Sam Kant, Dixon B Kaufman, Lenuta Micsa

|Jul 27, 2022
BK Virus Nephropathy in Kidney Transplantation: A State-of-the-Art Review.

Sam Kant, Alana Dasgupta, Serena Bagnasco

Pageof 2

Frequent Collaborators

2 joint publications

Christina Tamargo

2 joint publications

Matthew A Sparks

2 joint publications

Anna M Burgner

2 joint publications

Atlee Baker